Insmed, Inc. (INSM)
124.03
-1.74
(-1.38%)
USD |
NASDAQ |
Aug 24, 16:00
124.03
0.00 (0.00%)
After-Hours: 20:00
Insmed 1 Year Total Returns (Daily) : -5.15% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | -5.15% |
| August 20, 2026 | -3.38% |
| August 19, 2026 | 2.71% |
| August 18, 2026 | 0.94% |
| August 17, 2026 | 0.41% |
| August 14, 2026 | -3.14% |
| August 13, 2026 | 2.82% |
| August 12, 2026 | 8.43% |
| August 11, 2026 | 17.43% |
| August 10, 2026 | 23.00% |
| August 07, 2026 | 19.95% |
| August 06, 2026 | 19.14% |
| August 05, 2026 | -11.28% |
| August 04, 2026 | -11.23% |
| August 03, 2026 | -9.42% |
| July 31, 2026 | -8.09% |
| July 30, 2026 | -3.51% |
| July 29, 2026 | -1.79% |
| July 28, 2026 | 2.34% |
| July 27, 2026 | 0.75% |
| July 24, 2026 | 3.28% |
| July 23, 2026 | 3.84% |
| July 22, 2026 | 3.61% |
| July 21, 2026 | 5.68% |
| July 20, 2026 | 4.35% |
| Date | Value |
|---|---|
| July 17, 2026 | 3.98% |
| July 16, 2026 | 2.74% |
| July 15, 2026 | 6.75% |
| July 14, 2026 | 8.07% |
| July 13, 2026 | 11.16% |
| July 10, 2026 | 19.60% |
| July 09, 2026 | 22.59% |
| July 08, 2026 | 21.21% |
| July 07, 2026 | 16.39% |
| July 06, 2026 | 14.05% |
| July 02, 2026 | 13.60% |
| July 01, 2026 | 9.61% |
| June 30, 2026 | 5.94% |
| June 29, 2026 | 5.28% |
| June 26, 2026 | 1.61% |
| June 25, 2026 | -0.36% |
| June 24, 2026 | -2.30% |
| June 23, 2026 | -3.10% |
| June 22, 2026 | -3.97% |
| June 18, 2026 | -3.68% |
| June 17, 2026 | -1.82% |
| June 16, 2026 | -5.98% |
| June 15, 2026 | -1.29% |
| June 12, 2026 | 1.00% |
| June 11, 2026 | -1.29% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Alnylam Pharmaceuticals, Inc. | -49.48% |
| United Therapeutics Corp. | 65.17% |
| ACADIA Pharmaceuticals, Inc. | 19.02% |
| Biogen, Inc. | 55.82% |
| Gilead Sciences, Inc. | 29.10% |